Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Inhibition of the ubiquitin-proteasome system reduces the abundance of pyruvate dehydrogenase kinase 1 in cultured myotubes
ID
Kociper, Blaž
(
Author
),
ID
Škorja, Nives
(
Author
),
ID
Ogrizek, Ivana
(
Author
),
ID
Miš, Katarina
(
Author
),
ID
Pirkmajer, Sergej
(
Author
)
PDF - Presentation file,
Download
(4,92 MB)
MD5: F8AAE35EBE6D1A4C8A8B939C88510D72
URL - Source URL, Visit
https://link.springer.com/article/10.1007/s10974-024-09679-3
Image galllery
Abstract
Pyruvate dehydrogenase kinase (PDK), which phosphorylates the pyruvate dehydrogenase complex, regulates glucose metabolism in skeletal muscle. PDK1, an isozyme whose expression is controlled by hypoxia-inducible factor-1α (HIF-1α), is thought to play a role in muscle adaptation to hypoxia. While transcriptional upregulation of PDK1 by HIF-1α is well characterised, mechanisms controlling proteolysis of PDK1 in skeletal muscle have not been thoroughly investigated. Proteasome inhibitor MG132 paradoxically reduced the abundance of PDK1 in human cancer cells and rat L6 myotubes, suggesting that MG132 might direct PDK1 towards autophagic degradation. The objectives of our current study were to determine (1) whether MG132 suppresses PDK1 levels in primary human myotubes, (2) whether chloroquine, an inhibitor of autophagy, prevents MG132-induced suppression of PDK1 in L6 myotubes, and (3) whether PYR-41, an inhibitor of ubiquitination, suppresses PDK1 in L6 myotubes. Using qPCR and/or immunoblotting, we found that despite markedly upregulating HIF-1α protein, MG132 did not alter the PDK1 expression in cultured primary human myotubes, while it suppressed both PDK1 mRNA and protein in L6 myotubes. The PDK1 levels in L6 myotubes were suppressed also during co-treatment with chloroquine and MG132. PYR-41 markedly increased the abundance of HIF-1α in primary human and L6 myotubes, while reducing the abundance of PDK1. In L6 myotubes treated with PYR-41, chloroquine increased the abundance of the epidermal growth factor receptor, but did not prevent the suppression of PDK1. Collectively, our results suggest that cultured myotubes degrade PDK1 via a pathway that cannot be inhibited by MG132, PYR-41, and/or chloroquine.
Language:
English
Keywords:
chloroquine
,
hypoxia-inducible factor-1α
,
HIF-1α
,
MG132
,
myotubes
,
PYR-41
,
pyruvate dehydrogenase kinase 1
,
PDK1
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
Str. 155–169
Numbering:
Vol. 45, iss. 3
PID:
20.500.12556/RUL-160122
UDC:
616-092
ISSN on article:
1573-2657
DOI:
10.1007/s10974-024-09679-3
COBISS.SI-ID:
203573251
Publication date in RUL:
21.08.2024
Views:
236
Downloads:
36
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Journal of muscle research and cell motility
Shortened title:
J. muscle res. cell motil.
Publisher:
Springer Nature
ISSN:
1573-2657
COBISS.SI-ID:
513197337
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
klorokin
,
hipoksijsko inducibilni faktor-1α
,
HIF-1α
,
miocevke
,
piruvat dehidrogenaza kinaza 1
,
PDK1
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P3-0043
Name:
Molekularni mehanizmi razvoja in delovanja skeletne mišice
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J7-3153
Name:
Molekularni mehanizmi specifičnosti pri uravnavanju izločanja in delovanja citokinov mišičnega izvora
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back